SESSION 1 AGENDA – Spotlight on Ocular Oncology



Saturday May 22, 2021
6:00 AM PT | 8:00 AM CT | 9:00 AM ET

Other Time Zones:
10:00 AM Argentina/Brazil Time | 2:00 PM UK Time | 6:30 PM India Time | 9:00 PM China Time | 10:00 PM Japan Time


9:00 AM – Session Introduction

Part I: Companion diagnostics and new therapeutic targets

Aqueous humor to guide genetic based diagnosis in retinoblastoma

The role of cell free DNA as a diagnostic test in Retinoblastoma
Jasmine H Francis, MD

Circulating tumor cells and metastatic risk in uveal melanoma
Elin S. Gray, PhD

Vitreous proteomics for uveal melanoma
Vinit Mahajan, MD, PhD

Molecular guided clinical trial design in uveal melanoma
J. William Harbour, MD

Panel Discussion I:
Moderators: J. William Harbour, MD, Prithvi Mruthyunjaya, MD, MHS
Panelists: Jesse Berry, MD Jasmine H Francis, MD, Elin S. Gray, PhD, Vinit Mahajan, MD, PhD, Manoj Parulekar, MD, FRCS, OPHTH ED, FRCOPHTH, DNB

Part II: Redefining and optimizing local tumor control

Episcleral sustained release chemotherapy in retinoblastoma
Brenda L. Gallie, MD, FRCSC, CM, OOnt

Light activated immuno-targeting of uveal melanoma
Ivana K. Kim, MD

Dose reduction strategies for plaque brachytherapy
Miguel A. Materin, MD

Prospective clinical trial design for radiation retinopathy
Daniel F. Martin, MD

Panel Discussion II
Moderators: Brian Marr, MD, Arun Singh, MD
Panelists: Brenda L. Gallie, MD, FRCSC, CM, OOnt, Ivana K. Kim, MD, Daniel F. Martin, MD, Miguel A. Materin, MD

Part III: Emerging targets, Intelligence and Challenges

Active targeting in orbital oncology: lessons learned
Andrea L. Kossler, MD, FACS

Ocular toxicity and inflammation with systemic cancer therapies
Dan S. Gombos, MD, FACS

Machine Learning in ocular melanoma detection
Mandeep S. Sagoo, MB, BChir, PhD, FRCS, FRCOphth

AI based histopathologic tumor analysis
Zelia Maria Correa, MD, PhD

Panel Discussion III
Moderators: Jay Duker, MD, Mandeep S. Sagoo, MB, BChir, PhD, FRCS, FRCOphth
Panelists: Zelia Maria Correa, MD, PhD, Dan S. Gombos, MD, FACS, Andrea L. Kossler, MD, FACS, Alison Skalet, MD, PhD

Part IV: The biggest unmet need: Uveal melanoma metastatic disease

A Perspective on unmet needs in Uveal Melanoma
Carol L. Shields, MD

Activating a research network to tackle a yet uncured disease: COOG2
Thomas Aaberg, MD

Panel Discussion IV – Non CME
Moderators: Sunil Arani Reddy, MD, Sapna Patel, BA, MD
Panelists: Thomas Aaberg, MD, Mark Chin, MS, MBA, Bahija Jallal, PhD, Jose Lutzky, MD, FACP, Carol L. Shields, MD

12:30 PM – Adjournment


Please note: Faculty, times and talk title are subject to change.

In collaboration with:

iVista Medical Education, Inc.
Contact Us:

Stay Informed

Can't make this event? Subscribe here to stay informed on all upcoming events!